US 10416163
Method and treatment of recurring endometrial cancer with an inhibitor of USP14
granted A61KA61K31/55
Quick answer
US patent 10416163 (Method and treatment of recurring endometrial cancer with an inhibitor of USP14) held by Regents of the University of Minnesota expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regents of the University of Minnesota
- Grant date
- Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/55